raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:314652

Variant ABeta2M amyloidosis

Synonyms: Autosomal dominant beta2-microglobulinic amyloidosis

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A rare form of amyloidosis characterized by accumulation and extensive visceral deposition of an amyloidogenic variant of beta 2 microglobulin leading to progressive gastrointestinal dysfunction, Sjögren syndrome and autonomic neuropathy.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enVariant ABeta2M amyloidosisAutosomal dominant beta2-microglobulinic amyloidosis
frAmylose ABeta2M varianteAmylose à bêta-2 microglobuline autosomique dominante
deABeta2M-Amyloidose, varianteBeta-2-Mikroglobulin-Amyloidose, autosomal-dominante
esAmiloidosis variante ABeta2MAmiloidosis beta2-microglobulínica autosómica dominante
itAmiloidosi variante ABeta2MAmiloidosi beta2-microglobulinica autosomica dominante
nlVariant ABèta2M-amyloïdoseAutosomaal dominante bèta2-microglobuline-amyloïdose
ptAmiloidose variante ABeta2MAmiloidose beta2-microglobulinica autossómica dominante
plWariant amyloidozy ABeta2MAutosomalna dominująca amyloidoza z beta2-microglobuliną
csVarianta ABeta2M amyloidózyVarianta amyloidózy chronicky dialyzovaných · Autozomálně dominantní amyloidóza s beta2-mikroglobulinem
ukАмілоїдоз, варіант ABeta2MАутосомно-домінантний бета2-мікроглобуліновий амілоїдоз
zhAβ2M变异的淀粉样变常染色体显性β2-微球蛋白淀粉样沉积
trVaryant ABeta2M amiloidozOtozomal dominant beta2-mikroglobulinik amiloidoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM105200NTBTvalidated
ICD-10E85.1NTBTattributedvalidated
ICD-115D00.3NTBTindexvalidated
MONDO0017810Evalidated
UMLSC4302669Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
B2MDisease-causing germline mutation(s) inAssessedHGNC:914ENSG0000016671010970015q21.1beta-2-microglobulin22693999[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated22693999[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_22693999[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2021-03-01
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012622Chronic kidney disease
HP:0012185Constrictive median neuropathy
HP:0001917Renal amyloidosis
Occasional (29-5%)
HP:0012332Abnormal autonomic nervous system physiology
HP:0010286Abnormal salivary gland morphology
HP:0011805Abnormal skeletal muscle morphology
HP:0025015Abnormal vascular morphology
HP:0000157Abnormality of the tongue
HP:0100292Amyloidosis of peripheral nerves
HP:0003365Arthralgia of the hip
HP:0030843Cardiac amyloidosis
HP:0011915Cardiovascular calcification
HP:0012309Cutaneous amyloidosis
HP:0005244Gastrointestinal infarctions
HP:0012280Hepatic amyloidosis
HP:0031368Intestinal perforation
HP:0030839Knee pain
HP:0012065Multiple bony cystic lesions
HP:0002756Pathologic fracture
HP:0012664Reduced left ventricular ejection fraction
HP:0007141Sensorimotor neuropathy
HP:0030834Shoulder pain
HP:0002176Spinal cord compression
HP:0030836Wrist pain

Annotation source: 33112446[PMID]_32392555[PMID]_26333542[PMID]_31226597[PMID]_25750126[PMID]

7

Sources for this card